The 2nd antibody symposium, co-organised by p53 Laboratory, ASTAR Biomedical Sciences Institutes and Chugai Pharmabody Research, was held in Biopolis, Singapore. At the symposium, a total of 11 scientists presented updates in innovative antibody research that have since been conducted in ASTAR, the academia and the pharma industry to foster greater interaction. Following the brief overview of antibody drug discovery in Chugai and CPR by Dr. Nezu, Research Head of CPR, 4 scientists from Chugai and CPR had the privilege to introduce their innovative antibody technologies. They also took the opportunity to outline several research projects which Chugai and CPR are currently developing.
Category: Science Events
1st Antibody Symposium in Biopolis, Singapore
The antibody symposium co-organised by p53 Laboratory, ASTAR Biomedical Research Institutes and Chugai Pharmabody Research, was held among the scientists who are working in Biopolis, Singapore. Over the 200 participants enjoyed learning about the cutting-edge antibody research in ASTAR, the university and the industry. Chugai’ s innovative antibody technologies, such as recycling and sweeping antibody technology and bispecific antibody which was published online in Nature Medicine October edition, and CPR’ s research function and activities were shown at the symposium.
